Cofttek, China’s Largest Manufacturer of PEA, Draws Attention of Investors
LUOHE CITY, China, Feb 14, 2021 – (ACN Newswire) – Cofttek Holding Limited, a Chinese pharmaceutical manufacturer, has recently drawn the attention of investors, following the U.S. introduction of the FDA drug ultramicronized Palmitoylethanolamide (PEA) for COVID-19 patients. Cofttek is China’s largest manufacturer of ultramicronized Palmitoylethanolamide (PEA) raw materials. Following the U.S. news, orders at... » read more